Stocklytics Platform
Asset logo for symbol NTRA
Natera
NTRA63
$117.66arrow_drop_up4.21%$4.76
Asset logo for symbol NTRA
NTRA63

$117.66

arrow_drop_up4.21%

Income Statement (NTRA)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
EBIT-$43.90M-$74.31M-$84.53M-$116.12M-$116.67M
EBITDA-$35.98M-$63.65M-$74.11M-$105.57M-$107.90M
gross Profit$243.17M$208.60M$159.85M$120.99M$118.25M
NET Income-$37.46M-$67.59M-$78.03M-$109.03M-$110.80M
total Revenue$413.35M$367.74M$311.10M$268.30M$261.40M

Balance Sheet (NTRA)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
cash Equivalents-----
net Debt-$359.19M-$374.02M-$200.10M-$237.36M$52.69M
stockholders Equity$836.52M$794.11M$765.32M$784.65M$596.14M
total Assets$1.51B$1.46B$1.45B$1.44B$1.24B
total Debt$437.60M$439.79M$441.99M$431.34M$433.80M
total Liabilities$680.46M$674.09M$691.79M$661.86M$651.74M

Cash Flow (NTRA)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
financing Cash Flow$11.04M$6.46M$6.84M$236.00M$9.31M
free Cash Flow-$7.68M$6.68M-$67.65M-$38.65M-$87.35M
investing Cash Flow----$47.03M
operating Cash Flow$3.99M$27.00M-$58.12M-$29.55M-$78.38M

Natera (NTRA) Financials

Natera Inc. (NTRA) is a leading and innovative genetic testing company that provides advanced diagnostics to help patients and healthcare professionals make informed decisions. The company's financials reflect its strong market position and steady growth. The income statement shows Natera's revenues and expenses, with gross profit representing the difference between total revenue and the cost of goods sold. Net income from stockholders is the final result after deducting taxes and other expenses. Natera's total revenue has been steadily increasing, indicating the company's success in attracting customers and expanding its testing services. The balance sheet provides a snapshot of Natera's financial health, with total assets reflecting the company's investments and total liabilities representing its obligations. Natera's stockholders' equity reveals the company's net worth, while cash equivalents indicate its readily available cash resources. Net debt reveals Natera's overall debt situation, taking into account its cash reserves. The cash flow statement breaks down the sources and uses of cash, with operating cash flow reflecting Natera's core business activities. Financing cash flow represents the funds generated or used for debt and equity transactions, while investing cash flow shows the company's investment in assets or divestment of assets. Free cash flow is a measure of Natera's cash flow available for use after accounting for capital expenditures. The financials provide valuable insights into Natera's financial performance and position, demonstrating the company's success in the genetic testing market.
add Natera  to watchlist

Keep an eye on Natera

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media